The directors of the Life Science Corporate Finance and Advisory company iQ3Corp Limited (iQ3 Corp or Company) are pleased to announce that the Initial Public Offering (IPO) of iQ3 Corp closed as of 1 May 2015 with the offer heavily oversubscribed.
iQ3Corp expects to list on the Australian Securities Exchange later in May 2015 (ASX Code:IQ3). The offering will raise gross proceeds of $4,400,000 via the issue of 14,666,667 shares at $0.30 per share and the Company will have a market capitalisation of $30,545,000 on listing.
The IPO was oversubscribed, and accordingly applicants may not receive all of the shares they applied for. The allocation of shares will be determined at the Company’s discretion and in the manner set out in the Replacement Prospectus.
For further information, please download the pdf: